Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02507440Phase 4Completed
Phase 4, randomised, double-blind trial comparing Viscous Lidocaine with Placebo (2 arms). Primary endpoint: Time from study drug administration to discharge at 3 hours. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02507440.